Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of APD356 in the Treatment of Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy male or nonpregnant, nonlactating females aged 18-65 years (inclusive)~* Body mass index (BMI) of 30-45 kg/m2~* Non-smoker~* No concomitant medications other than hypertension medications (stable \> 90 days) and/or statins (stable \> 90 days)~* No past treatment with drugs associated with the development of pulmonary hypertension or cardiac valvular insufficiency~* No more than mild mitral valve regurgitation and absence of aortic valve regurgitation upon screening echocardiogram

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).